Minted: - / 5000

2097 Brilanestrant
5b22113ee130040a2cb827f089f4d08c2a029e03d0f2c3d65fc1b227870c8b73

Properties

Background

Green
Bottle

Gray
Cap

Gray
Syringe

Pink
Bubbles
No
Drops
No
Label
Cross

Chemistry

Formula
C26H20ClFN2O2
Carbon
26
Polarity
Neutral

Brilanestrant (INN) (developmental code names GDC-0810, ARN-810, RG-6046, RO-7056118) is a nonsteroidal combined selective estrogen receptor modulator (SERM) and selective estrogen receptor degrader (SERD) that was discovered by Aragon Pharmaceuticals and was under development by Genentech for the treatment of locally advanced or metastatic estrogen receptor (ER)-positive breast cancer.

From Wikipedia, the free encyclopedia. License: CC BY-SA.